Scopus by Title (Ref)

1. Development of sustainable N,S carbon quantum dots turn-off fluorescence method for rivastigmine determination using box-behnken design in pharmaceutical and environmental applications

- Serag A. , et al.

2. Determination of Alzheimer's Drugs in a Human Urine Sample by Different Chemometric Methods

- Pekcan G. , et al.

3. Oral Dissolving Film of Rivastigmine: Optimization Using Factorial Design

- Farghaly D.A. , et al.

4. Validated LC/MS/MS Method for the Determination of Rivastigmine in Human Plasma: Application to a Pharmacokinetic Study in Egyptian Volunteers to Determine the Effect of Gender and Body Mass Index

- ElKady E.F. , et al.

5. The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease

- Valis M. , et al.

6. QbD-driven HPLC method for the quantification of rivastigmine in rat plasma and brain for pharmacokinetics study

- Gopalan D. , et al.

7. Development of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS/MS) Method to Determine the Presence of Rivastigmine in Human Plasma in Clinical Studies of Comparative Pharmacokinetics

- Dolov M.S. , et al.

8. Rivastigmine modifies the α-secretase pathway and potentially early Alzheimer’s disease

- Ray B. , et al.

9. Donepezil and rivastigmine: Pharmacokinetic profile and brain-targeting after intramuscular administration in rats

- Karasova J.Z. , et al.

10. Preparation, Optimization, and Evaluation of Methoxy Poly(ethylene glycol)- co-Poly(ϵ-caprolactone) Nanoparticles Loaded by Rivastigmine for Brain Delivery

- Mohamadpour H. , et al.

11. Optimization of chromatography to overcome matrix effect for reliable estimation of four small molecular drugs from biological fluids using LC–MS/MS

- Trivedi V. , et al.

12. Gel-based microemulsion design and evaluation for topical application of rivastigmine

- Fang C.W. , et al.

13. A determination approach for rivastigmine by lepidocrocite nanoparticles supported on N-chitosan carbon nanosheets/Anti-fouling PAS: Application to biosensing

- Mohamed F.A. , et al.

14. A Stability Indicating HPLC Assay Method for Analysis of Rivastigmine Hydrogen Tartrate in Dual-Ligand Nanoparticle Formulation Matrices and Cell Transport Medium

- Huda N.H. , et al.

15. Enhancement of oral bioavailability of rivastigmine with quercetin nanoparticles by inhibiting CYP3A4 and esterases

- Palle S. , et al.

16. Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles

- Salatin S. , et al.

17. Concentration of Donepezil in the Cerebrospinal Fluid of AD Patients: Evaluation of Dosage Sufficiency in Standard Treatment Strategy

- Valis M. , et al.

18. CuO nanoparticles-catalyzed hydrogen peroxide–sodium hydrogen carbonate chemiluminescence system used for quenchometric determination of atorvastatin, rivastigmine and topiramate

- Iranifam M. , et al.

19. Bupropion Hydrochloride

- Khan S.R. , et al.

20. Review of the validated HPLC and LC-MS/MS methods for determination of drugs used in clinical practice for Alzheimer's disease

- Ponnayyan Sulochana S. , et al.

21. Rapid HILIC method for assay and dissolution analysis of rivastigmine hydrogen tartrate from hydrophilic matrix

- Saraiva F. , et al.

22. Advantages of the incorporation of 2-hydroxyl propyl beta cyclodextrin and calixarene as ionophores in potentiometric ion-selective electrodes for rivastigmine with a kinetic study of its alkaline degradation

- El-Sayed M. , et al.

23. Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety

- Nagpal K. , et al.

24. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting

- Fazil M. , et al.

25. A validated RP-HPLC method for estimation of Rivastigmine in pharmaceutical formulations

- Alexandar A. , et al.